Financial Ratios Exponent, Inc.

Stocks

EXPO

US30214U1025

Business Support Services

Market Closed - Nasdaq 16:00:00 2026-10-01 EDT			5-day change	1st Jan Change
69.90 ^USD	+6.85%		+8.44%	+0.63%

07-31	UBS Adjusts Exponent Price Target to $72 From $75, Maintains Neutral Rating	MT
07-30	Exponent, Inc., Q2 2026 Earnings Call, Jul 30, 2026

1af002582b2d3febef4b.U1je21oBiMfTBjTwnUZyRqQC3JjtLgQP4_AJDT-7SpQ.FzOcgxteuvSQbkOcynMmI-ZDkferZEI40sRvUlbVL-IgEZiqHjf7sqdTeQ

Published financial data: EXPONENT, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: January	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	435M	464M	497M	518M	537M
Total Revenues	435M	464M	497M	518M	537M
Cost of Goods Sold, Total	278M	264M	320M	330M	342M
Gross Profit	157M	200M	177M	188M	195M
Selling General & Admin Expenses, Total	23.9M	32.62M	34.98M	36.56M	40.8M
Other Operating Expenses	23.98M	26.12M	31M	32.36M	34.18M
Other Operating Expenses, Total	47.88M	58.74M	65.98M	68.92M	74.98M
Operating Income	109M	141M	111M	120M	120M
Interest And Investment Income	66K	2.1M	7.15M	10M	9.31M
Net Interest Expenses	66K	2.1M	7.15M	10M	9.31M
Currency Exchange Gains (Loss)	-517K	522K	-259K	-14K	-158K
Other Non Operating Income (Expenses)	17.36M	-11.23M	17.68M	17.83M	18.36M
EBT, Excl. Unusual Items	126M	132M	136M	147M	147M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
EBT, Incl. Unusual Items	126M	132M	136M	147M	147M
Income Tax Expense	24.64M	29.9M	35.56M	38.37M	41.29M
Earnings From Continuing Operations	101M	102M	100M	109M	106M
Net Income to Company	101M	102M	100M	109M	106M
Net Income - (IS)	101M	102M	100M	109M	106M
Net Income to Common Incl Extra Items	101M	102M	100M	109M	106M
Net Income to Common Excl. Extra Items	101M	102M	100M	109M	106M
Per Share Items
Net EPS - Basic	1.92	1.98	1.96	2.13	2.08
Basic EPS - Continuing Operations	1.92	1.98	1.96	2.13	2.08
Basic Weighted Average Shares Outstanding	52.61M	51.73M	51.15M	51.13M	50.9M
Net EPS - Diluted	1.9	1.96	1.94	2.11	2.07
Diluted EPS - Continuing Operations	1.9	1.96	1.94	2.11	2.07
Diluted Weighted Average Shares Outstanding	53.33M	52.28M	51.64M	51.57M	51.24M
Normalized Basic EPS	1.49	1.6	1.66	1.8	1.81
Normalized Diluted EPS	1.47	1.58	1.64	1.79	1.8
Dividend Per Share	0.8	0.96	1.04	1.12	1.2
Payout Ratio	42.68	48.12	53.86	53.41	58.05
Supplemental Items
EBITDA	115M	148M	120M	129M	130M
EBITA	109M	141M	111M	120M	120M
EBIT	109M	141M	111M	120M	120M
EBITDAR	124M	157M	131M	143M	145M
Total Revenues (As Reported)	466M	513M	537M	559M	582M
Effective Tax Rate - (Ratio)	19.58	22.61	26.16	26.04	28.03
Current Domestic Taxes	28.39M	35.29M	33.22M	38.63M	48.99M
Current Foreign Taxes	2.25M	1.97M	2.25M	3.04M	2.24M
Total Current Taxes	30.64M	37.27M	35.47M	41.67M	51.24M
Deferred Domestic Taxes	-6M	-7.36M	85K	-3.3M	-9.95M
Total Deferred Taxes	-6M	-7.36M	85K	-3.3M	-9.95M
Normalized Net Income	78.65M	82.65M	84.94M	92.11M	92.06M
Supplemental Operating Expense Items
General and Administrative Expenses	15.28M	23.66M	24.44M	22.73M	25.52M
Net Rental Expense, Total	8.61M	8.96M	10.54M	13.83M	15.28M
Stock-Based Comp., COGS (Total)	18.49M	19.64M	19.62M	22.51M	23.04M
Stock-Based Comp., G&A Exp. (Total)	772K	719K	734K	730K	754K
Total Stock-Based Compensation	19.26M	20.36M	20.36M	23.24M	23.8M

Fiscal Period: January	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	298M	161M	187M	259M	222M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	298M	161M	187M	259M	222M
Accounts Receivable, Total	140M	170M	167M	161M	182M
Total Receivables	140M	170M	167M	161M	182M
Prepaid Expenses	5.83M	6.29M	11M	9M	8.08M
Other Current Assets, Total	9.38M	11.29M	14.02M	17.58M	16.06M
Total Current Assets	453M	349M	380M	447M	428M
Gross Property Plant And Equipment	173M	187M	204M	260M	267M
Accumulated Depreciation	-98.4M	-103M	-104M	-112M	-122M
Net Property Plant And Equipment	74.34M	83.55M	99.92M	148M	145M
Goodwill	8.61M	8.61M	8.61M	8.61M	8.61M
Deferred Tax Assets Long-Term	46.55M	53.91M	53.82M	57.13M	67.08M
Other Long-Term Assets, Total	101M	91.44M	105M	116M	129M
Total Assets	684M	587M	647M	777M	778M
Liabilities
Accounts Payable, Total	3.19M	8.64M	4.49M	5.27M	6.87M
Accrued Expenses, Total	125M	126M	129M	136M	145M
Current Portion of Leases	5.16M	5.26M	6.3M	5.39M	6.89M
Unearned Revenue Current, Total	19.76M	18.83M	21.71M	16.37M	18.87M
Total Current Liabilities	153M	159M	162M	163M	178M
Long-Term Leases	9.81M	13.34M	21.96M	76.08M	75.94M
Other Non Current Liabilities	104M	93.54M	107M	117M	133M
Total Liabilities	267M	266M	291M	356M	387M
Common Stock, Total	66K	66K	66K	66K	66K
Additional Paid In Capital	281M	301M	321M	346M	370M
Retained Earnings	478M	529M	574M	624M	668M
Treasury Stock	-341M	-506M	-537M	-545M	-646M
Comprehensive Income and Other	-1.98M	-3.59M	-2.98M	-3.79M	-2.29M
Total Common Equity	417M	321M	356M	421M	390M
Total Equity	417M	321M	356M	421M	390M
Total Liabilities And Equity	684M	587M	647M	777M	778M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	52.12M	50.64M	50.56M	50.82M	49.25M
ECS Total Common Shares Outstanding	52.12M	50.64M	50.57M	50.81M	49.62M
Book Value / Share	8	6.33	7.04	8.29	7.87
Tangible Book Value	408M	312M	347M	412M	382M
Tangible Book Value Per Share	7.84	6.16	6.87	8.12	7.69
Total Debt	14.97M	18.6M	28.26M	81.48M	82.83M
Net Debt	-283M	-143M	-159M	-177M	-139M
Debt Equivalent Oper. Leases	68.91M	71.71M	84.33M	111M	122M
Account Code - Inventory Valuation	-	-	-	3	3
Land - (BS)	18.34M	18.34M	18.34M	18.34M	18.34M
Buildings, Total	64.85M	69.6M	69.7M	70.42M	70.42M
Machinery, Total	60.96M	65.11M	66.42M	70.79M	76.54M
Full Time Employees	1.22K	1.31K	1.32K	1.17K	1.21K
Accumulated Allowance for Doubtful Accounts (Supple)	4.42M	6.19M	5.28M	6.14M	7.48M

Fiscal Period: January	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	101M	102M	100M	109M	106M
Depreciation & Amortization - CF	6.49M	7.08M	8.92M	9.69M	10.08M
Depreciation & Amortization, Total	6.49M	7.08M	8.92M	9.69M	10.08M
(Gain) Loss on Sale of Investments - (CF)	-11K	-	-	-	-
Stock-Based Compensation (CF)	19.26M	20.36M	20.36M	23.24M	23.8M
Provision and Write-off of Bad Debts	1.96M	3.08M	3.22M	4.45M	2.99M
Other Operating Activities, Total	-6M	-7.36M	85K	-3.3M	-9.95M
Change In Accounts Receivable	-30.25M	-33.33M	-471K	1.5M	-23.09M
Change In Accounts Payable	8.44M	2.22M	-5.06M	436K	7.68M
Change in Unearned Revenues	7.96M	-928K	2.88M	-5.34M	2.5M
Change in Other Net Operating Assets	15.52M	363K	-2.92M	4.86M	11.71M
Cash from Operations	125M	93.81M	127M	145M	132M
Capital Expenditure	-6.83M	-12.04M	-16.36M	-6.94M	-9.39M
Investment in Marketable and Equity Securities, Total	45M	-	-	-	-
Cash from Investing	38.18M	-12.04M	-16.36M	-6.94M	-9.39M
Issuance of Common Stock	3.11M	2.02M	2.18M	5.74M	2.37M
Repurchase of Common Stock	-22.67M	-169M	-34.15M	-12.63M	-101M
Common Dividends Paid	-43.2M	-49.24M	-54.04M	-58.21M	-61.54M
Common & Preferred Stock Dividends Paid	-43.2M	-49.24M	-54.04M	-58.21M	-61.54M
Cash from Financing	-62.75M	-216M	-86.01M	-65.11M	-160M
Foreign Exchange Rate Adjustments	169K	-2.02M	705K	-739K	1.12M
Net Change in Cash	100M	-136M	25.69M	71.75M	-36.97M
Supplemental Items
Cash Income Tax Paid (Refund)	27.91M	40.12M	38.94M	39.72M	48M
Levered Free Cash Flow	92.73M	76.76M	79.65M	107M	95.01M
Unlevered Free Cash Flow	92.73M	76.76M	79.65M	107M	95.01M
Change In Net Working Capital	-5.73M	26.67M	2.85M	-6.58M	4.35M

Fiscal Period: January	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	10.77	13.86	11.28	10.49	9.63
Return on Total Capital	16.73	22.82	19.23	16.85	15.35
Return On Equity %	26	27.74	29.65	28.05	26.13
Return on Common Equity	26	27.74	29.65	28.05	26.13
Margin Analysis
Gross Profit Margin %	36.06	43.03	35.66	36.35	36.29
SG&A Margin	5.5	7.03	7.04	7.05	7.6
EBITDA Margin %	26.54	31.89	24.18	24.93	24.2
EBITA Margin %	25.05	30.37	22.39	23.06	22.32
EBIT Margin %	25.05	30.37	22.39	23.06	22.32
Income From Continuing Operations Margin %	23.27	22.06	20.18	21.02	19.75
Net Income Margin %	23.27	22.06	20.18	21.02	19.75
Net Avail. For Common Margin %	23.27	22.06	20.18	21.02	19.75
Normalized Net Income Margin	18.09	17.82	17.08	17.76	17.15
Levered Free Cash Flow Margin	21.32	16.55	16.02	20.69	17.7
Unlevered Free Cash Flow Margin	21.32	16.55	16.02	20.69	17.7
Asset Turnover
Asset Turnover	0.69	0.73	0.81	0.73	0.69
Fixed Assets Turnover	5.67	5.88	5.42	4.18	3.66
Receivables Turnover (Average Receivables)	3.46	2.99	2.95	3.15	3.13
Short Term Liquidity
Current Ratio	2.96	2.2	2.34	2.74	2.4
Quick Ratio	2.86	2.08	2.19	2.58	2.27
Operating Cash Flow to Current Liabilities	0.81	0.59	0.79	0.89	0.74
Days Sales Outstanding (Average Receivables)	105.23	121.63	123.54	117.62	116.27
Average Days Payable Outstanding	4.24	8.15	7.47	5.49	6.46
Long Term Solvency
Total Debt/Equity	3.59	5.8	7.94	19.35	21.22
Total Debt / Total Capital	3.47	5.48	7.35	16.21	17.51
LT Debt/Equity	2.35	4.16	6.17	18.07	19.46
Long-Term Debt / Total Capital	2.27	3.93	5.71	15.14	16.05
Total Liabilities / Total Assets	39	45.33	44.94	45.83	49.8
Total Debt / EBITDA	0.12	0.12	0.22	0.57	0.57
Net Debt / EBITDA	-2.28	-0.91	-1.21	-1.24	-0.96
Total Debt / (EBITDA - Capex)	0.13	0.13	0.25	0.6	0.61
Net Debt / (EBITDA - Capex)	-2.41	-0.99	-1.39	-1.3	-1.02
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	14.91	6.66	7.19	4.28	3.52
Gross Profit, 1 Yr. Growth %	22.15	27.28	-11.16	6.3	3.34
EBITDA, 1 Yr. Growth %	28.07	28.17	-18.71	7.49	0.48
EBITA, 1 Yr. Growth %	30.84	29.3	-20.96	7.4	0.19
EBIT, 1 Yr. Growth %	30.84	29.3	-20.96	7.4	0.19
Earnings From Cont. Operations, 1 Yr. Growth %	22.59	1.11	-1.95	8.63	-2.75
Net Income, 1 Yr. Growth %	22.59	1.11	-1.95	8.63	-2.75
Normalized Net Income, 1 Yr. Growth %	29.81	5.08	2.77	8.44	-0.05
Diluted EPS Before Extra, 1 Yr. Growth %	22.58	3.16	-1.02	8.76	-1.9
Accounts Receivable, 1 Yr. Growth %	25.36	21.63	-1.62	-3.56	12.45
Net Property, Plant and Equip., 1 Yr. Growth %	-6.07	12.38	19.6	48.38	-1.95
Total Assets, 1 Yr. Growth %	17.87	-14.2	10.25	20.18	0.03
Tangible Book Value, 1 Yr. Growth %	15.75	-23.58	11.32	18.7	-7.45
Common Equity, 1 Yr. Growth %	15.37	-23.09	11.02	18.25	-7.3
Cash From Operations, 1 Yr. Growth %	20.57	-24.69	35.76	13.49	-8.86
Capital Expenditures, 1 Yr. Growth %	36.88	76.43	35.81	-57.58	35.32
Levered Free Cash Flow, 1 Yr. Growth %	27.67	-17.23	3.77	34.72	-11.45
Unlevered Free Cash Flow, 1 Yr. Growth %	27.67	-17.23	3.77	34.72	-11.45
Dividend Per Share, 1 Yr. Growth %	5.26	20	8.33	7.69	7.14
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.41	10.71	6.93	5.73	3.9
Gross Profit, 2 Yr. CAGR %	6.14	24.69	6.34	-2.82	4.81
EBITDA, 2 Yr. CAGR %	12.06	28.12	2.07	-6.53	3.93
EBITA, 2 Yr. CAGR %	13.13	30.07	1.09	-7.87	3.73
EBIT, 2 Yr. CAGR %	13.13	30.07	1.09	-7.87	3.73
Earnings From Cont. Operations, 2 Yr. CAGR %	10.78	11.34	-0.43	3.21	2.79
Net Income, 2 Yr. CAGR %	10.78	11.34	-0.43	3.21	2.79
Normalized Net Income, 2 Yr. CAGR %	9.58	16.8	3.92	5.57	4.11
Diluted EPS Before Extra, 2 Yr. CAGR %	11.44	12.45	1.05	3.76	3.3
Accounts Receivable, 2 Yr. CAGR %	7.9	23.48	9.39	-2.59	4.14
Net Property, Plant and Equip., 2 Yr. CAGR %	-6.25	2.74	15.93	33.21	20.61
Total Assets, 2 Yr. CAGR %	10.16	0.56	-2.74	15.1	9.64
Tangible Book Value, 2 Yr. CAGR %	9.34	-5.95	-7.77	14.95	4.81
Common Equity, 2 Yr. CAGR %	9.12	-5.8	-7.6	14.58	4.7
Cash From Operations, 2 Yr. CAGR %	7.37	-4.71	1.11	24.13	1.7
Capital Expenditures, 2 Yr. CAGR %	-45.57	55.4	54.79	-24.09	-24.23
Levered Free Cash Flow, 2 Yr. CAGR %	24.57	2.8	-7.32	18.23	9.22
Unlevered Free Cash Flow, 2 Yr. CAGR %	24.57	2.8	-7.32	18.23	9.22
Dividend Per Share, 2 Yr. CAGR %	11.8	12.39	14.02	8.01	7.42
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.03	5.82	9.53	6.04	4.99
Gross Profit, 3 Yr. CAGR %	3.95	12.76	11.37	6.33	-0.81
EBITDA, 3 Yr. CAGR %	5.69	17.19	10.09	3.85	-4.25
EBITA, 3 Yr. CAGR %	6	18.28	10.17	3.15	-5.25
EBIT, 3 Yr. CAGR %	6	18.28	10.17	3.15	-5.25
Earnings From Cont. Operations, 3 Yr. CAGR %	11.89	7.46	6.72	2.51	1.18
Net Income, 3 Yr. CAGR %	11.89	7.46	6.72	2.51	1.18
Normalized Net Income, 3 Yr. CAGR %	10.48	8.06	11.92	5.41	3.66
Diluted EPS Before Extra, 3 Yr. CAGR %	12.62	8.61	7.77	3.56	1.84
Accounts Receivable, 3 Yr. CAGR %	9.74	12.29	14.47	4.89	2.18
Net Property, Plant and Equip., 3 Yr. CAGR %	17.26	-0.41	8.08	25.87	20.27
Total Assets, 3 Yr. CAGR %	13.39	1.36	3.69	4.37	9.84
Tangible Book Value, 3 Yr. CAGR %	10.19	-2.97	-0.51	0.33	6.94
Common Equity, 3 Yr. CAGR %	9.93	-2.89	-0.5	0.32	6.76
Cash From Operations, 3 Yr. CAGR %	10.96	-4.61	7.22	5.08	11.98
Capital Expenditures, 3 Yr. CAGR %	-25.18	-19.44	48.58	0.55	-7.96
Levered Free Cash Flow, 3 Yr. CAGR %	9.62	8.7	3.12	4.98	7.37
Unlevered Free Cash Flow, 3 Yr. CAGR %	9.62	8.7	3.12	4.98	7.37
Dividend Per Share, 3 Yr. CAGR %	15.44	14.47	11.02	11.87	7.72
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.76	7.07	6.99	5.79	7.24
Gross Profit, 5 Yr. CAGR %	8.19	10.83	4.9	6.25	8.69
EBITDA, 5 Yr. CAGR %	11.15	13.56	4.23	7.05	7.58
EBITA, 5 Yr. CAGR %	11.96	14.35	4.01	7.03	7.55
EBIT, 5 Yr. CAGR %	11.96	14.35	4.01	7.03	7.55
Earnings From Cont. Operations, 5 Yr. CAGR %	16.34	19.89	6.79	5.74	5.13
Net Income, 5 Yr. CAGR %	16.34	19.89	6.79	5.74	5.13
Normalized Net Income, 5 Yr. CAGR %	12.73	9.89	7.81	7.06	8.73
Diluted EPS Before Extra, 5 Yr. CAGR %	16.91	20.55	7.84	6.64	5.96
Accounts Receivable, 5 Yr. CAGR %	9.86	9.09	9.6	6.08	10.22
Net Property, Plant and Equip., 5 Yr. CAGR %	15.16	19	16.73	11.88	12.93
Total Assets, 5 Yr. CAGR %	11.11	5.94	6.64	6.65	6.03
Tangible Book Value, 5 Yr. CAGR %	9.06	2.16	2.62	3.84	1.58
Common Equity, 5 Yr. CAGR %	8.82	2.1	2.55	3.75	1.55
Cash From Operations, 5 Yr. CAGR %	13.22	6.7	6.91	5.99	4.98
Capital Expenditures, 5 Yr. CAGR %	-13.86	20.58	0.07	-21.34	13.49
Levered Free Cash Flow, 5 Yr. CAGR %	15.87	6.2	2.5	12.42	5.52
Unlevered Free Cash Flow, 5 Yr. CAGR %	15.87	6.2	2.5	12.42	5.52
Dividend Per Share, 5 Yr. CAGR %	17.32	17.98	14.87	11.84	9.57